[1]
“RETROSPECTIVE ANALYSIS OF NIMOTUZUMAB VS CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS RECEIVING CONCURRENT RADIOTHERAPY”, ijmsdr, vol. 5, no. 6, Jun. 2021, doi: 10.32553/ijmsdr.v5i6.804.